人参
化学
苷元
细菌
生物化学
原人参二醇
脂肪酸
人参皂甙
前药
肠道细菌
酶
生物
糖苷
立体化学
医学
病理
遗传学
替代医学
标识
DOI:10.1254/jphs.fmj04001x4
摘要
Orally ingested ginsenoside passes through the stomach and small intestine without decomposition by either gastric juice or liver enzymes into the large intestine, where ginsenoside is deglycosylated by colonic bacteria followed by transit to the circulation. Colonic bacteria cleave the oligosaccharide connected to the aglycone stepwise from the terminal sugar to afford the major metabolites, 20S-protopanaxadiol 20-O-beta-D-glucopyranoside (M1) and 20S-protopanaxatriol (M4). These metabolites are further esterified with fatty acids. The resultant fatty-acid conjugates are still active molecules that are sustained longer in the body than parental metabolites. Accumulating evidence strongly suggests that ginsenoside is a prodrug that is activated in the body by intestinal bacterial deglycosylation and fatty acid esterification.
科研通智能强力驱动
Strongly Powered by AbleSci AI